| EASL Clinical Practice Guidelines: management of hepatitis C virus infection European Association For The Study Of The Liver Journal of hepatology 55 (2), 245-264, 2011 | 2219 | 2011 |
| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 1260 | 2020 |
| EASL recommendations on treatment of hepatitis C 2018 JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ... Journal of hepatology 69 (2), 461-511, 2018 | 518 | 2018 |
| A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis R D'Ambrosio, A Aghemo, MG Rumi, G Ronchi, MF Donato, V Paradis, ... Hepatology 56 (2), 532-543, 2012 | 407 | 2012 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The Lancet Gastroenterology & Hepatology 4 (2), 135-184, 2019 | 303 | 2019 |
| Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ... Hepatology 53 (3), 791-799, 2011 | 285 | 2011 |
| Randomized study of peginterferon-α2a plus ribavirin vs peginterferon-α2b plus ribavirin in chronic hepatitis C MG Rumi, A Aghemo, GM Prati, R D'Ambrosio, MF Donato, R Soffredini, ... Gastroenterology 138 (1), 108-115, 2010 | 281 | 2010 |
| COVID-19 and liver disease J Sun, A Aghemo, A Forner, L Valenti Wiley 40 (6), 1278-1281, 2020 | 268 | 2020 |
| EASL recommendations on treatment of hepatitis C: final update of the series☆ JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ... Journal of hepatology 73 (5), 1170-1218, 2020 | 246 | 2020 |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19 M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ... Journal of hepatology 73 (5), 1063-1071, 2020 | 240 | 2020 |
| EASL recommendations on treatment of hepatitis C 2014 European Association for The Study of The Liver Journal of hepatology 61 (2), 373-395, 2014 | 238 | 2014 |
| Recommendations for the management of hepatitis C virus infection among people who inject drugs J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, ... International Journal of Drug Policy 26 (10), 1028-1038, 2015 | 183 | 2015 |
| Treatment with ledipasvir–sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial M Colombo, A Aghemo, H Liu, J Zhang, H Dvory-Sobol, R Hyland, C Yun, ... Annals of internal medicine 166 (2), 109-117, 2017 | 178 | 2017 |
| Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection F Marabita, A Aghemo, S De Nicola, MG Rumi, C Cheroni, R Scavelli, ... Hepatology 54 (4), 1127-1134, 2011 | 171 | 2011 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 1-10, 2017 | 169 | 2017 |
| New horizons in hepatitis C antiviral therapy with direct‐acting antivirals A Aghemo, R De Francesco Hepatology 58 (1), 428-438, 2013 | 160 | 2013 |
| The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response R D’Ambrosio, A Aghemo, M Fraquelli, MG Rumi, MF Donato, V Paradis, ... Journal of hepatology 59 (2), 251-256, 2013 | 156 | 2013 |
| Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method A Tripodi, M Primignani, L Lemma, V Chantarangkul, A Dell'Era, ... Hepatology 52 (1), 249-255, 2010 | 156 | 2010 |
| Hepatitis C virus treatment in the real world: optimising treatment and access to therapies F Zoulim, TJ Liang, AL Gerbes, A Aghemo, S Deuffic-Burban, G Dusheiko, ... Gut 64 (11), 1824-1833, 2015 | 142 | 2015 |
| A review of the treatment of chronic hepatitis C virus infection in cirrhosis E Vezali, A Aghemo, M Colombo Clinical therapeutics 32 (13), 2117-2138, 2010 | 140 | 2010 |
